A Minimal and Portable CRISPR Platform Based on Bifidobacterial Cas9 Enables Genome Editing in E. coli Nissle 1917
Authors:
- 31 January 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 15 (4) , 1544-1556
Abstract
Genetic manipulation of core gut probiotics remains challenging due to endogenous cellular barriers and a scarcity of efficient molecular tools, limiting progress in live biotherapeutic development. Here, we characterized the native type II-C CRISPR-Cas system in Bifidobacterium longum subsp. longum GNB (B. longum GNB). Through integrated bioinformatic analysis and high-throughput protospacer adjacent motif (PAM) screening, we identified a novel 5'-NNRMAT-3' (where R = A/G, M = A/C) motif recognized by its compact Cas9 nuclease (BLCas9). The stringent PAM dependency of BLCas9 was unequivocally confirmed by in vitro cleavage assays. Leveraging this endogenous mechanism, we developed a dual-plasmid editing platform for robust and multiplex genome engineering in the probiotic strain Escherichia coli Nissle 1917 (EcN). Application of this system notably enhanced extracellular γ-aminobutyric acid (GABA) production in EcN through targeted metabolic engineering. Our work provides the first molecular dissection of a type II-C system in Bifidobacterium longum and establishes a generalizable framework for the discovery and application of compact programmable nucleases, suggesting a viable strategy for modulating host physiology via the gut-brain axis.Keywords
Funding Information
- National Key Research and Development Program of China (2022YFA0912200)
- Fundamental Research Funds for the Central Universities (2662022SKPY001)
- National Natural Science Foundation of China (32170096)
This publication has 62 references indexed in Scilit:
- A Review of Next-Generation Probiotics—As a Gateway to BiotherapeuticsProbiotics and Antimicrobial Proteins, 2025
- Strategies in engineering sustainable biochemical synthesis through microbial systemsCurrent Opinion in Chemical Biology, 2024
- Relieving metabolic burden to improve robustness and bioproduction by industrial microorganismsBiotechnology Advances, 2024
- High-level production of γ-aminobutyric acid via efficient co-expression of the key genes of glutamate decarboxylase system in Escherichia coliEngineering Microbiology, 2023
- Structural basis for Cas9 off-target activityCell, 2022
- Controlling CRISPR‐Cas9 by guide RNA engineeringWIREs RNA, 2022
- CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV VectorsCell, 2020
- A Compact, High-Accuracy Cas9 with a Dinucleotide PAM for In Vivo Genome EditingMolecular Cell, 2019
- Structural Basis for the Canonical and Non-canonical PAM Recognition by CRISPR-Cpf1Molecular Cell, 2017
- Biotechnological advances and perspectives of gamma-aminobutyric acid productionWorld Journal of Microbiology and Biotechnology, 2017